Cardior develops novel, noncoding (ncRNA) RNA therapeutics for patients with myocardial infarction / heart failure.

Pharmaceutical

Cardior

Cardior's headquarters in Hannover, Germany

Claudia Ulbrich

Dr. Steffen Rump

Andreas Kranzusch

Dipl. Biol. Barbara Gärtner-Rupprecht

Wilfried Hauke

Thomas Thum

Frank Kalkbrenner

Johann Bauersachs

Ulrich Granzer

Faiez Zannad

Douglas L. Mann

Karin Kleinhans

Javed Butler

David Crandall

Scott Solomon

Markus Hosang

Arthur A. Levin

The Advisory and Board Team at Cardior provides strategic guidance and oversight, ensuring the company's mission to develop innovative ncRNA therapeutics for myocardial infarction and heart failure is effectively pursued. This team leverages its expertise to support decision-making, secure funding, and foster industry partnerships.

Advisory and Board Team

The Clinical and Research Team at Cardior is responsible for conducting and overseeing clinical trials, developing research protocols, ensuring drug safety, and maintaining high-quality standards for novel ncRNA therapeutics aimed at treating myocardial infarction and heart failure. This team collaborates closely to translate scientific discoveries into effective treatments, ensuring compliance with regulatory standards and optimizing clinical outcomes.


Clinical and Research Team

This department focuses on managing communication strategies and ensuring quality standards in research and development processes.

Communications and Quality

This department manages financial strategies and protects intellectual assets.

Finance and Intellectual Property

The Leadership Team at Cardior is responsible for setting the strategic direction and vision of the company as it develops innovative ncRNA RNA therapeutics for myocardial infarction and heart failure. This team, composed of the CEO, CSO, and CMO, collaborates to drive key decisions in research, development, and clinical initiatives while fostering a culture of innovation and ensuring alignment with patient needs and regulatory requirements.

Leadership Team

The Operations Team at Cardior oversees the development and implementation of organizational strategies to ensure efficient, compliant, and high-quality production of ncRNA therapeutics. This includes managing project timelines, maintaining regulatory standards, and optimizing operational processes to support cardiovascular disease treatments.

Cardior

Org chart

Board & advisors

Teams

Advisory and Board Team

Clinical and Research Team

Communications and Quality

Finance and Intellectual Property

Leadership Team

Operations Team

Offices

Cardior

Org chart

Board & advisors

Teams

Advisory and Board Team

Clinical and Research Team

Communications and Quality

Finance and Intellectual Property

Leadership Team

Operations Team

Offices

Related companies